Association of blood levels of components of the urokinase system of plasminogen activation with prostate cancer presence, invasion, progression, and metastasis

被引：0
|
作者：
Shariat, Shahrokh F.
Roehrbom, Claus G.
McConnell, John D.
Park, Sangtae
Wheeler, Thomas M.
Slawin, Kevin M.
机构：
来源：
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)31634-3
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：473 / 473
页数：1
相关论文
共 50 条
  • [41] Role of urokinase-type plasminogen activator and inhibitory effect of protease inhibitor in invasion and metastasis of pancreatic cancer
    Kawazoe, Y
    Sawada, T
    Chung, YS
    Sowa, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 10 (05) : 983 - 987
  • [42] Targeting of urokinase-type plasminogen activator receptor in oral cancer cells inhibits invasion and metastasis in vivo
    Nozaki, Shinichi
    Endo, Yoshio
    Nakahara, Hirokazu
    Yoshizawa, Kunio
    Hashiba, Yukari
    Kawashiri, Shuichi
    Tanaka, Akira
    Nakagawa, Kiyomasa
    Yamamoto, Etsuhide
    CANCER RESEARCH, 2006, 66 (08)
  • [43] Association of polymorphisms in the genes of the urokinase plasminogen activation system with susceptibility to and severity of non-small cell lung cancer
    Shih, Chuen-Ming
    Kuo, Wu-Hsien
    Lin, Chiao-Wen
    Chen, Wei
    Cheng, Wei-Erh
    Chen, Shuo-Chueh
    Lee, Yao-Ling
    CLINICA CHIMICA ACTA, 2011, 412 (1-2) : 194 - 198
  • [44] RETRACTION: Demethylation-Linked Activation of Urokinase Plasminogen Activator Is Involved in Progression of Prostate Cancer (Retraction of Vol 67, Pg 930, 2007)
    Pulukuri, S. M. K.
    Estes, N.
    Patel, J.
    Rao, J. S.
    CANCER RESEARCH, 2018, 78 (12) : 3397 - 3397
  • [45] Plasminogen system association with angiogenesis in advanced prostate cancer.
    Kaushal, V
    Spencer, HJ
    Mehta, P
    BLOOD, 2002, 100 (11) : 70B - 70B
  • [46] Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis
    Nozaki, S
    Endo, Y
    Kawashiri, S
    Nakagawa, K
    Yamamoto, E
    Yonemura, Y
    Sasaki, T
    ORAL ONCOLOGY, 1998, 34 (01) : 58 - 62
  • [47] Effect of glucocorticoids on the plasminogen activator system in the metastatic progression of prostate cancer
    Dondi, D
    Festuccia, C
    Bologna, M
    Demissie, M
    Poletii, A
    Montagnani-Marelli, M
    Motta, M
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 371 - 372
  • [48] suPAR, a soluble form of urokinase plasminogen activator receptor, inhibits human prostate cancer cell growth and invasion
    Piccolella, M.
    Festuccia, C.
    Millimaggi, D.
    Locatelli, A.
    Bologna, M.
    Motta, M.
    Dondi, D.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 32 (01) : 185 - 191
  • [49] Correlation of transcript levels of members of the urokinase-type plasminogen activator system with clinico-pathological parameters in prostate cancer
    Al-Janabi, Omar
    Taubert, Helge
    Wach, Sven
    Stoehr, Robert
    Burger, Maximilian
    Wieland, Wolf Ferdinand
    Lohse-Fischer, Andrea
    Froehner, Michael
    Wirth, Manfred P.
    Wullich, Bernd
    Magdolen, Viktor
    Kotzsch, Matthias
    Fuessel, Susanne
    CANCER RESEARCH, 2013, 73 (08)
  • [50] The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis
    Brungs, Daniel
    Chen, Julia
    Aghmesheh, Morteza
    Vine, Kara L.
    Becker, Therese M.
    Carolan, Martin G.
    Ranson, Marie
    ONCOTARGET, 2017, 8 (14) : 23099 - 23109
12345